Lista de obras - Raymond S Douglas - Dominio Público Uruguay

"En-glove" lysis of lower eyelid retractors with AlloDerm and dermis-fat grafts in lower eyelid retraction surgery.

scientific article published on March 2011

Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis.

artículo científico publicado en 2007

Aesthetic lateral canthoplasty.

artículo científico publicado en 2010

An Aesthetic Orbicularis Oculi Myectomy Technique for Blepharospasm: Use of Topical 5-Fluorouracil and Fibrin Sealant.

artículo científico publicado en 2017

B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis.

artículo científico publicado en 2008

CD40 Expression in Fibrocytes Is Induced by TSH: Potential Synergistic Immune Activation

artículo científico publicado en 2016

Circulating mononuclear cells from euthyroid patients with thyroid-associated ophthalmopathy exhibit characteristic phenotypes.

artículo científico publicado en 2007

Compressive Optic Neuropathy and Repeat Orbital Decompression: A Case Series

artículo científico publicado en 2014

Congenital lacrimal sac fistula: intraoperative visualization by polyvinyl siloxane cast.

artículo científico publicado en 2008

Dermatofibrosarcoma protuberans metastatic to the orbit

artículo científico publicado en 2004

Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique

artículo científico publicado en 2009

Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease.

artículo científico publicado en 2008

Eyelid Swelling and Proptosis with Systemic Implications.

artículo científico publicado en 2016

Facial recontouring with autogenous fat

artículo científico publicado en 2004

Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease.

artículo científico publicado en 2011

Graves' orbitopathy

scientific article published on 01 February 2007

Histopathology of brow fat in thyroid-associated orbitopathy.

artículo científico publicado en 2012

Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease.

artículo científico publicado en 2006

Immunopathogenesis of thyroid eye disease: emerging paradigms

artículo científico publicado en 2010

Increased CD40+ Fibrocytes in Patients With Idiopathic Orbital Inflammation.

artículo científico publicado en 2015

Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production.

artículo científico publicado en 2012

Increased generation of fibrocytes in thyroid-associated ophthalmopathy

artículo científico publicado en 2009

Interleukin-4 induces 15-lipoxygenase-1 expression in human orbital fibroblasts from patients with Graves disease. Evidence for anatomic site-selective actions of Th2 cytokines.

artículo científico publicado en 2006

Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB.

artículo científico publicado en 2012

Island pedicle and horizontal advancement cheek flaps for medial canthal reconstruction.

artículo científico publicado en 2011

Long-term efficacy of biomodeled polymethyl methacrylate implants for orbitofacial defects.

artículo científico publicado en 2006

Non-surgical treatment for eyelid retraction in thyroid eye disease (TED).

artículo científico publicado en 2017

Nuclear targeting of IGF-1 receptor in orbital fibroblasts from Graves' disease: apparent role of ADAM17

artículo científico publicado en 2012

Orbital and periorbital infections

artículo científico publicado en 2012

Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1.

scientific article published on 30 December 2008

Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA

artículo científico publicado en 2011

Orbital wall fracture repair using Seprafilm.

artículo científico publicado en 2009

PGE2 induces IL-6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: implications to thyroid-associated ophthalmopathy

artículo científico publicado en 2010

Periocular Reconstruction in Patients with Facial Paralysis

artículo científico publicado en 2016

Pharmacological treatments for thyroid eye disease.

artículo científico publicado en 2006

Pharmacotherapy: does selenium supplementation improve Graves ophthalmopathy?

artículo científico publicado en 2011

Reactivation of thyroid-associated orbitopathy after cataract surgery.

artículo científico publicado en 2009

Reliability of estimating ductions in thyroid eye disease: an International Thyroid Eye Disease Society multicenter study

artículo científico publicado en 2011

Rituximab (Rituxan) therapy for severe thyroid-associated ophthalmopathy diminishes IGF-1R(+) T cells

artículo científico publicado en 2014

Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy

artículo científico publicado en 2009

Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy.

artículo científico publicado en 2012

TSH-Mediated TNFα Production in Human Fibrocytes Is Inhibited by Teprotumumab, an IGF-1R Antagonist

artículo científico publicado en 2015

Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab

artículo científico publicado en 2011

Teprotumumab for Thyroid-Associated Ophthalmopathy.

artículo científico publicado en 2017

Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes.

artículo científico publicado en 2014

The pathophysiology of thyroid eye disease.

artículo científico

The pathophysiology of thyroid eye disease: implications for immunotherapy.

artículo científico publicado en 2011

Thyroid-associated orbitopathy: Current insights into the pathophysiology, immunology and management.

artículo científico publicado en 2010

Thyroid-associated periorbitopathy: eyebrow fat and soft tissue expansion in patients with thyroid-associated orbitopathy

artículo científico publicado en 2012

Thyrotropin and CD40L Stimulate Interleukin-12 Expression in Fibrocytes: Implications for Pathogenesis of Thyroid-Associated Ophthalmopathy.

artículo científico publicado en 2016

Thyrotropin receptor and CD40 mediate interleukin-8 expression in fibrocytes: implications for thyroid-associated ophthalmopathy (an American Ophthalmological Society thesis)

artículo científico publicado en 2014

Treatment of lower eyelid retraction by expansion of the lower eyelid with hyaluronic Acid gel.

artículo científico publicado en 2007

Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy.

artículo científico publicado en 2008

Lista de obras de Raymond S Douglas

"En-glove" lysis of lower eyelid retractors with AlloDerm and dermis-fat grafts in lower eyelid retraction surgery.

Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis.

Aesthetic lateral canthoplasty.

An Aesthetic Orbicularis Oculi Myectomy Technique for Blepharospasm: Use of Topical 5-Fluorouracil and Fibrin Sealant.

B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis.

CD40 Expression in Fibrocytes Is Induced by TSH: Potential Synergistic Immune Activation

Circulating mononuclear cells from euthyroid patients with thyroid-associated ophthalmopathy exhibit characteristic phenotypes.

Compressive Optic Neuropathy and Repeat Orbital Decompression: A Case Series

Congenital lacrimal sac fistula: intraoperative visualization by polyvinyl siloxane cast.

Dermatofibrosarcoma protuberans metastatic to the orbit

Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique

Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease.

Eyelid Swelling and Proptosis with Systemic Implications.

Facial recontouring with autogenous fat

Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease.

Graves' orbitopathy

Histopathology of brow fat in thyroid-associated orbitopathy.

Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease.

Immunopathogenesis of thyroid eye disease: emerging paradigms

Increased CD40+ Fibrocytes in Patients With Idiopathic Orbital Inflammation.

Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production.

Increased generation of fibrocytes in thyroid-associated ophthalmopathy

Interleukin-4 induces 15-lipoxygenase-1 expression in human orbital fibroblasts from patients with Graves disease. Evidence for anatomic site-selective actions of Th2 cytokines.

Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB.

Island pedicle and horizontal advancement cheek flaps for medial canthal reconstruction.

Long-term efficacy of biomodeled polymethyl methacrylate implants for orbitofacial defects.

Non-surgical treatment for eyelid retraction in thyroid eye disease (TED).

Nuclear targeting of IGF-1 receptor in orbital fibroblasts from Graves' disease: apparent role of ADAM17

Orbital and periorbital infections

Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1.

Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA

Orbital wall fracture repair using Seprafilm.

PGE2 induces IL-6 in orbital fibroblasts through EP2 receptors and increased gene promoter activity: implications to thyroid-associated ophthalmopathy

Periocular Reconstruction in Patients with Facial Paralysis

Pharmacological treatments for thyroid eye disease.

Pharmacotherapy: does selenium supplementation improve Graves ophthalmopathy?

Reactivation of thyroid-associated orbitopathy after cataract surgery.

Reliability of estimating ductions in thyroid eye disease: an International Thyroid Eye Disease Society multicenter study

Rituximab (Rituxan) therapy for severe thyroid-associated ophthalmopathy diminishes IGF-1R(+) T cells

Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy

Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy.

TSH-Mediated TNFα Production in Human Fibrocytes Is Inhibited by Teprotumumab, an IGF-1R Antagonist

Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab

Teprotumumab for Thyroid-Associated Ophthalmopathy.

Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes.

The pathophysiology of thyroid eye disease.

The pathophysiology of thyroid eye disease: implications for immunotherapy.

Thyroid-associated orbitopathy: Current insights into the pathophysiology, immunology and management.

Thyroid-associated periorbitopathy: eyebrow fat and soft tissue expansion in patients with thyroid-associated orbitopathy

Thyrotropin and CD40L Stimulate Interleukin-12 Expression in Fibrocytes: Implications for Pathogenesis of Thyroid-Associated Ophthalmopathy.

Thyrotropin receptor and CD40 mediate interleukin-8 expression in fibrocytes: implications for thyroid-associated ophthalmopathy (an American Ophthalmological Society thesis)

Treatment of lower eyelid retraction by expansion of the lower eyelid with hyaluronic Acid gel.

Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy.